NCT05589584View on ClinicalTrials.gov

N-acetyl Cysteine and Patients with Non-alcoholic Fatty Liver Disease

PHASE3CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

May 20, 2024

Study Completion Date

August 1, 2024

Conditions

Simple Steatosis Non Fatty Liver

Interventions

DRUG

N acetyl cysteine with weight reduction

high dose 2400mg/day

Trial Locations (1)

Unknown

NHTMRI, Cairo

All Listed Sponsors

lead

Ain Shams University

OTHER